UChicago Medicine Faculty Physicians
Seenu M. Hariprasad, MD
Seenu M. Hariprasad, MD
UChicago Medicine Faculty Physicians
Shui-Chin Lee Professor of Ophthalmology and Visual Science
Director, Clinical Research
Chief, Vitreoretinal Service
Chair, Department of Ophthalmology and Visual Science
Director, Fellowship in the Diseases and Surgery of the Retina, Macula and Vitreous
Specialties
- Ophthalmology
Locations
- Chicago - Hyde Park
Schedule an Appointment
Loading...
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Seenu M. Hariprasad, MD, has been named the department's first Shui-Chin Lee Professor in Ophthalmology and Visual Science and is an active leader in the department. Dr. Hariprasad is an internationally recognized vitreoretinal surgeon specializing in the diseases and surgery of the retina, vitreous, and macula.
Since joining the University of Chicago Medicine in 2005, Dr. Hariprasad has gained a reputation as a leading specialist in various vitreoretinal disorders, including AMD, diabetic eye disease, intraocular infection and RVO. He has been recognized for bringing more effective and efficient sutureless microincisional vitrectomy techniques to the medical center.
Dr. Hariprasad's clinical research has contributed to the understanding and use of new medications to combat a wide variety of vitreoretinal disorders. He has served as principal or sub-investigator in more than 45 national and international clinical trials evaluating various medications, sustained drug-delivery devices and surgical innovations to treat a variety of diseases, such as AMD, diabetic retinopathy and RVO.
His work has led to nearly 200 peer-reviewed publications, meeting abstracts and textbook chapters. He has presented more than 150 individual lectures in cities around the world. Dr. Hariprasad's recently published textbook, Management of Retinal Vein Occlusion: Current Concepts, is one of only a small number of textbooks dedicated to this disease.
He has also been awarded numerous honors, including an AAO Achievement Award and an ASRS Honor Achievement Award, and has been named a top doctor in publications such as US News & World Report and Chicago Magazine.
Since joining the University of Chicago Medicine in 2005, Dr. Hariprasad has gained a reputation as a leading specialist in various vitreoretinal disorders, including AMD, diabetic eye disease, intraocular infection and RVO. He has been recognized for bringing more effective and efficient sutureless microincisional vitrectomy techniques to the medical center.
Dr. Hariprasad's clinical research has contributed to the understanding and use of new medications to combat a wide variety of vitreoretinal disorders. He has served as principal or sub-investigator in more than 45 national and international clinical trials evaluating various medications, sustained drug-delivery devices and surgical innovations to treat a variety of diseases, such as AMD, diabetic retinopathy and RVO.
His work has led to nearly 200 peer-reviewed publications, meeting abstracts and textbook chapters. He has presented more than 150 individual lectures in cities around the world. Dr. Hariprasad's recently published textbook, Management of Retinal Vein Occlusion: Current Concepts, is one of only a small number of textbooks dedicated to this disease.
He has also been awarded numerous honors, including an AAO Achievement Award and an ASRS Honor Achievement Award, and has been named a top doctor in publications such as US News & World Report and Chicago Magazine.
Specialties
Areas of Expertise
- Diabetic Eye Diseases
- Endophthalmitis
- Retinal Vein Occlusions
- Epiretinal Membrane
- Diabetic Retinopathy
- Uveitis
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park5758 S. Maryland Ave., Chicago IL 606371-888-824-0200
Board Certifications
- Ophthalmology
Practicing Since
- 2005
Languages Spoken
- English
- Hindi
- Spanish
- Tamil
- Telugu
Medical Education
- University of Pennsylvania School of Medicine
Internship
- Baylor College of Medicine Medical Center
Residency
- Baylor College of Medicine Medical Center
Fellowship
- Barnes-Jewish Hospital
Memberships & Medical Societies
- American College of Physicians
- Association for Research in Vision and Ophthalmology
- Retina Society
- American Society of Cataract and Refractive Surgery
- Macula Society
- Chicago Ophthalmological Society
- American Medical Association
- American Society of Retina Specialists
- CONNECT Network
- European Society of Retina Specialists
- American Academy of Ophthalmology
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.